查詢結果分析
來源資料
相關文獻
- Cyclosporine-Induced Encephalopathy in a Patient with Relapsed Acute Myeloid Leukemia Treated with Unrelated Allogeneic Bone Marrow Transplantation
- Sympathetic Ophthalmia Associated with Cyclitis: Case Report
- 急性骨髓性白血病
- 海洋性貧血患童ABO 血型不合之異體骨髓移植
- Graft Versus Host Disease in Allogeneic Bone Marrow Transplantation
- Mandibular Osteomyelitis Caused by Blastoschizomyces Capitatus in a Child with Acute Myelogenous Leukemia
- 急性骨髓性白血病化學治療最近的進展
- The Clinical Experience of Cyclosporin A Therapy in Primary Glomerulonephritis
- Therapy of Acute Myelogenous Leukemia: Results of Combination Chemotherapy with Cytarabine, Daunorubicin and 6-Mercaptopurine
- 白血病合併顏面嚴重血腫與壞死性筋膜炎--病例報告
頁籤選單縮合
題名 | Cyclosporine-Induced Encephalopathy in a Patient with Relapsed Acute Myeloid Leukemia Treated with Unrelated Allogeneic Bone Marrow Transplantation=環孢靈素引起急性腦病變發生於一復發急性骨髓性白血病接受異體骨髓移植患者 |
---|---|
作者 | 陳宇欽; 趙祖怡; 陳震宇; 何景良; Chen, Yeu-chin; Chao, Tsu-yi; Chen, Cheng-yu; Ho, Ching-liang; |
期刊 | 臺灣醫學會雜誌 |
出版日期 | 20000300 |
卷期 | 99:3 2000.03[民89.03] |
頁次 | 頁248-251 |
分類號 | 415.635 |
語文 | eng |
關鍵詞 | 環孢靈素; 急性腦病變; 急性骨髓性白血病; 異體骨髓移植; Cyclosporine; Encephalopathy; Acute myeloid leukemia; Allogeneic bone marrow transplantation; |
英文摘要 | Cyclosporine (CSP) is the most frequently used immunosuppressive agent for prevention of graft versus host disease (GVHD) in allogeneic bone marrow transplantation (BMT). Some adverse effects such as hepatic and renal toxicity have been frequently encountered, but central nervous system (CNS) toxicity caused by CSP is rare. We report an adult male patient with acute myeloid leukemia who developed CSP-induced encephalopathy under treatment for allogeneic BMT from an unrelated donor. Methotrexate and CSP were used for GVHD prophylaxis. Leukocyte and platelet engraftment were successfully achieved on days 21 and 24 after BMT, respectively. Abrupt onset of mental confusion and disorientation occurred on day 25, followed by a generalized tonic clonic seizure and consciousness disturbance. The whole blood CSP level was 160.65 ng/mL. Magnetic resonance (MR) imaging revealed high signal intensities in the bilateral occipital lobes with predominant involvement of the cortical areas. The patient recovered from the CNS toxicity, but with slight memory impairment, 6 days after CSP was discontinued. When patients receiving CSP treatment for allogeneic BMT develop mental confusion, consciousness disturbance, or seizure, CSP-induced CNS toxicity should be taken into consideration. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。